Who is best suited to anti-TNF monotherapy?

Anti-TNF monotherapy in rheumatoid arthritis is relatively common but it is not always clear who are the best candidates for this treatment.

Now a Canadian study suggests RA patients in remission after six months of etanercept plus methotrexate can safely drop the methotrexate without worsening their condition.

Study participants with low disease activity after six months of combination therapy had a